* The study involves predicting the 3D model of GPR78, conducting virtual screening for potential drug compounds, and simulating their interactions in a lipid environment to analyze binding energies and dynamics.
* Findings reveal that lead compounds interact favorably with GPR78, indicating its dynamic nature and suggesting that targeting this orphan receptor could lead to new treatments for CNS-related disorders.